May 3, 2018 | LITTLE ROCK – The public is invited to learn about the latest advances in gynecologic cancers and cancer genetics at a free event sponsored by the University of Arkansas for Medical Sciences (UAMS).
The program will be held at 6:30 p.m. May 24 at Moix RV Supercenter, 800 N. Creek Drive, in Conway. Featured speaker will be Kristin Zorn, M.D., director of the UAMS Division of Gynecologic Oncology and Hereditary Gynecologic Cancer Clinic. Zorn also is associate professor in the UAMS College of Medicine Department of Obstetrics and Gynecology and Division of Genetics.
There is no charge to attend, and hors d’oeuvres will be served. To make a reservation, call (501) 686-7327 by May 17.
This event is presented by the UAMS Winthrop P. Rockefeller Cancer Institute. It is sponsored by Moix RV Supercenter and the Envoys, an advocacy group of the Winthrop P. Rockefeller Cancer Institute Foundation.UAMS is the state's only health sciences university, with colleges of Medicine, Nursing, Pharmacy, Health Professions and Public Health; a graduate school; a hospital; a main campus in Little Rock; a Northwest Arkansas regional campus in Fayetteville; a statewide network of regional campuses; and seven institutes: the Winthrop P. Rockefeller Cancer Institute, Jackson T. Stephens Spine & Neurosciences Institute, Harvey & Bernice Jones Eye Institute, Psychiatric Research Institute, Donald W. Reynolds Institute on Aging, Translational Research Institute and Institute for Digital Health & Innovation. UAMS includes UAMS Health, a statewide health system that encompasses all of UAMS' clinical enterprise. UAMS is the only adult Level 1 trauma center in the state. UAMS has 3,240 students, 913 medical residents and fellows, and five dental residents. It is the state's largest public employer with more than 11,000 employees, including 1,200 physicians who provide care to patients at UAMS, its regional campuses, Arkansas Children's, the VA Medical Center and Baptist Health. Visit www.uams.edu or uamshealth.com. Find us on Facebook, Twitter, YouTube or Instagram.